Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silan Fidan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMC Medical Ethics|January 19, 2026
Navigating DNACPR decisions: a qualitative study of DNACPR factor variability and implementation among NHS DoctorsSilan Fidan, Simon Cohn
BMJ Open Respiratory Research|November 19, 2021
Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort studyShaney L Barratt, Andrew W Creamer, Huzaifa I Adamali, et al.
Eclinicalmedicine|December 9, 2022
Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosisTheresia A Mikolasch, Peter M George, Jagdeep Sahota, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMC Medical Ethics|January 19, 2026
Navigating DNACPR decisions: a qualitative study of DNACPR factor variability and implementation among NHS DoctorsSilan Fidan, Simon Cohn
BMJ Open Respiratory Research|November 19, 2021
Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort studyShaney L Barratt, Andrew W Creamer, Huzaifa I Adamali, et al.
Eclinicalmedicine|December 9, 2022
Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosisTheresia A Mikolasch, Peter M George, Jagdeep Sahota, et al.
Pageof 1